Intrathecal Drug Delivery of Antisense Oligonucleotides in Huntington's Disease: Experience of Ionis/Roche RG6042 Development Programme and Best Practice Considerations for Real-World Use (2019)
Attributed to:
MICA: HD-CSF: Studying cerebrospinal fluid to understand key CNS pathobiological targets in Huntington's disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 16
Parent Publication: NEUROTHERAPEUTICS
Issue: 4
ISSN: 1933-7213